Clinical Trials Sponsored by Nora Therapeutics, Inc.

Total 3074 results

Nora Therapeutics, Inc.

Unknown

A Multi-center, Placebo-controlled Study to Evaluate NT100 in Pregnant Women With a History of Unexplained Recurrent Pregnancy Loss (RPL) (RESPONSE)

Recurrent Miscarriage | Recurrent Pregnancy Loss

United Kingdom
Nora Therapeutics, Inc.

Completed

Follow-Up Of Pregnancies Established During Study NT-03 (Thrive-IVF Follow-Up) (Thrive-IVF F/U)

Repeated IVF Failure
Nora Therapeutics, Inc.

Completed

A Multi-Center Study To Evaluate Multiple Doses of NT100 Following IVF In Women With Repeated IVF Failures (Thrive-IVF) (Thrive-IVF)

Repeated IVF Failure

United States
ORA, Inc.
Stuart Therapeutics, Inc.

Recruiting

Safety and Efficacy of ST-100 (Vezocolmitide) Ophthalmic Solution 60 μg/ml Ophthalmic Solution in Subjects Diagnosed With Dry Eye Disease (DED)

Dry Eye Disease

United States
LENZ Therapeutics, Inc
ORA, Inc.

Completed

Phase 3 Safety Study for the Treatment of Presbyopia Subjects

Eye Diseases | Presbyopia | Miosis | Near Vision

United States
LENZ Therapeutics, Inc
ORA, Inc.

Completed

Phase 3 Efficacy Study of LNZ101 for the Treatment of Presbyopia (CLARITY)

Eye Diseases | Presbyopia | Miosis | Near Vision

United States
LENZ Therapeutics, Inc
ORA, Inc.

Completed

Plasma Pharmacokinetics and Safety of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Subjects With Presbyopia

Eye Diseases | Refractive Errors | Presbyopia | Ophthalmic Solutions | Brimonidine Tartrate | Aceclidine

United States
Aldeyra Therapeutics, Inc.
ORA, Inc.

Completed

A Study of ADX-102 in Subjects With Allergic Conjunctivitis

Conjunctivitis, Allergic

United States
Stuart Therapeutics, Inc.
ORA, Inc.

Completed

Study of ST-100 as Treatment for Dry Eye Disease

Dry Eye Disease

United States
LENZ Therapeutics, Inc
ORA, Inc.

Completed

Evaluation of the Safety and Effectiveness of Aceclidine/Brimonidine (LNZ101) and Aceclidine (LNZ100) in the Treatment of Presbyopia

Eye Diseases | Refractive Errors | Presbyopia

United States
LENZ Therapeutics, Inc
ORA, Inc.

Completed

Phase 3 Evaluation of the Safety and Efficacy of LNZ101 for the Treatment of Presbyopia (CLARITY)

Eye Diseases | Refractive Error | Presbyopia | Miosis | Near Vision

United States
Ocular Therapeutix, Inc.
ORA, Inc.

Completed

OTX-14-006: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Dry Eye

Dry Eye
Ocular Therapeutix, Inc.
ORA, Inc.

Completed

OTX-15-002: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis

Chronic Allergic Conjunctivitis
Ocular Therapeutix, Inc.
ORA, Inc.

Completed

OTX-14-001: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis

Chronic Allergic Conjunctivitis
Ocular Therapeutix, Inc.
ORA, Inc.

Completed

OTX-14-007: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis

Chronic Allergic Conjunctivitis
3E Therapeutics Corporation
ORA, Inc.

Completed

Allergen Biocube Study Evaluating Efficacy and Safety of Nasapaque Nasal Solution in Adult Subjects With Allergic Rhinitis

Seasonal Allergic Rhinitis
Alisyn Facemire
ORA, Inc.

Completed

Evaluation of the Safety and Effectiveness of Aceclidine (LNZ101) and Aceclidine + Brimonidine (LNZ100) in the Treatment of Presbyopia

Eye Diseases | Refractive Errors | Presbyopia | Miosis | Near Vision

United States
ORA, Inc.

Withdrawn

Efficacy Study of Ketorolac and HPMC to Treat Dry Eye

Dry Eye

United States
ORA, Inc.

Completed

An Allergen BioCube (ABC) Study Evaluating the Efficacy of Fluticasone Propionate Nasal Spray Compared to Placebo

Allergic Rhinitis | Allergic Conjunctivitis

United States
ORA, Inc.

Completed

A Single-Center Evaluation of the Anti-Inflammatory Effects of Lastacaft as Measured by In-Vivo Confocal Microscopy

Allergic Conjunctivitis
ORA, Inc.

Completed

Safety and Efficacy Study of a Testosterone Eye Drop for the Treatment of Meibomian Gland Dysfunction

Meibomian Gland Dysfunction

United States
ORA, Inc.

Completed

Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model

Allergic Conjunctivitis

United States
ORA, Inc.

Completed

Study Evaluating Nasal Symptoms Induced by a Nasal Allergen Challenge (NAC) To House Dust Mite Allergen

Allergic Rhinitis

United States
ORA, Inc.

Completed

Effect of Controlled Adverse Environment (CAE) on Tear Film Stability

Keratoconjunctivitis Sicca

United States
ORA, Inc.

Withdrawn

An Allergen BioCube (ABC) Study Evaluating the Onset of Action of Fluticasone Furoate Nasal Spray and Olopatadine Nasal Spray Compared to Placebo

Allergic Rhinitis
ORA, Inc.

Terminated

Visual Function Tests in Age-related Macular Degeneration

Age Related Macular Degeneration

United States
ORA, Inc.

Completed

Study Evaluating the Efficacy and Safety of PRT-2761 for the Treatment of Acute and Chronic Allergic Conjunctivitis

Allergic Conjunctivitis

United States
ORA, Inc.

Completed

Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model

Allergic Conjunctivitis

United States
ORA, Inc.

Completed

Food Allergy Diagnostic Test Response to Previous Oral Challenge Response

Food Hypersensitivity

United States
ORA, Inc.

Completed

A Single-Center Pilot Study to Assess Macular Function

Macular Degeneration

United States
ORA, Inc.

Completed

A Pilot Study Evaluating the Signs and Symptoms of Seasonal Allergic Rhinoconjunctivitis Following Exposure in the Allergen BioCube

Allergic Rhinoconjunctivitis

United States
ORA, Inc.

Completed

A Single-Center Evaluation of the Pattern of Allergic Signs and Symptoms During 4 Weeks in Ragweed Season

Allergic Conjunctivitis

United States
ORA, Inc.

Withdrawn

A Clinical Study Comparing the Comfort of Three Commercially Available Contact Lenses

Contact Lens Complication

United States
ORA, Inc.

Completed

Symptom Response in Normal and Dry Eye Patients Secondary to Application of a Menthol-Containing Eyedrop (Rohto® Hydra)

Dry Eye
ORA, Inc.

Completed

Mucin Levels in Dry Eye and Normal Populations

Dry Eye

United States
ORA, Inc.

Completed

Evaluation of Prednisolone in a Modified Conjunctival Allergen Challenge Model

Chronic Allergic Conjunctivitis

United States
ORA, Inc.

Completed

Flicker Fusion Thresholds Between Young and Old Subjects at Various Luminance Levels

Age-related Macular Degeneration | Age Factor

United States
ORA, Inc.

Completed

Conjunctival Allergen Challenge (CAC) Following Allergen Exposure in the Allergen BioCube (ABC) (ABC CAC)

Allergic Rhinoconjunctivitis

United States
Nova Eye, Inc.

Terminated

Multicenter Ab-interno Glaucoma Study Investigating Canaloplasty (MAGIC)

Primary Open Angle Glaucoma

United States
Therapeutics, Inc.

Completed

Safety, Tolerability, and Pharmacokinetics of UHE-103 Cream in Subjects With Tinea Cruris and/or Tinea Pedis

Tinea Pedis | Tinea Cruris

United States
Therapeutics, Inc.

Completed

A Study of the Safety and Efficacy of UHE-105 Shampoo in Subjects With Scalp Psoriasis

Scalp Psoriasis

United States
Therapeutics, Inc.

Completed

A Phase 2 Safety and Efficacy Study of UHE-101 Cream in Subjects With Acne Vulgaris

Acne Vulgaris

United States
Therapeutics, Inc.

Completed

A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 306)

Plaque Psoriasis

United States
Therapeutics, Inc.

Completed

A Study to Determine the Efficacy and Safety of 122-0551 in Subjects With Plaque Psoriasis

Psoriasis | Plaque Psoriasis

United States
Therapeutics, Inc.

Completed

A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -305)

Plaque Psoriasis

United States
BlackThorn Therapeutics, Inc.
Neumora Therapeutics, Inc.

Completed

Study in Major Depressive Disorder With BTRX-335140 (NMRA-335140) vs Placebo

Major Depressive Disorder

United States
Sirion Therapeutics, Inc.
ReVision Therapeutics, Inc.

Completed

Study of Fenretinide in the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular Degeneration

Geographic Atrophy | Dry Age Related Macular Degeneration
Hoffmann-La Roche
Tempest Therapeutics; Adagene Inc; Immune-Onc Therapeutics; NiKang Therapeutics...

Recruiting

A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)

Advanced Liver Cancers

Korea, Republic of, Taiwan, United States, Israel, China, France, New Zealand
Therapeutics, Inc.

Completed

Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis (307)

Plaque Psoriasis

United States
Therapeutics, Inc.

Completed

A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 310)

Plaque Psoriasis

United States

3

Subscribe